Nu-Med Plus acquisition by YourSpace terminated; CEO Russ Colvin resigns, William Hayde appointed CEO

Nu-Med Plus, Inc.

YourSpace terminated share exchange agreement on Oct 28, 2024, failing to provide audited 2023 financials.
Russ Colvin resigned as President/CEO and Director upon termination; William Hayde appointed as President/CEO.
No change in control occurred; no securities were issued under the agreement.
William Hayde remains Executive Chairman; Keith Merrell continues as CFO and Director; Jeffrey Robins continues as Director.

item 2.01 item 3.02 item 5.01 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

William Hayde

President/Chief Executive Officer

NUMD · Nu-Med Plus, Inc.

Effective: 2024-10-28
Filed: October 30, 2024, 7:59 PM ET

On October 28, 2024, the Board of Directors appointed Mr. William Hayde, who is the Chairman of the Board, to serve as President/Chief Executive Officer of Nu-Med.

Departed

Russ Colvin

President/Chief Executive Officer and Director

NUMD · Nu-Med Plus, Inc.

Effective: 2024-10-28
Successor: William Hayde
Filed: October 30, 2024, 7:59 PM ET

Mr. Colvin submitted his resignation from the positions to which he had been appointed.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

William Hayde was appointed as President/Chief Executive Officer at Nu-Med Plus, Inc..

Action: appointed
Role: President/Chief Executive Officer

Exact text from the filing

On October 28, 2024, the Board of Directors appointed Mr. William Hayde, who is the Chairman of the Board, to serve as President/Chief Executive Officer of Nu-Med.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Russ Colvin resigned as President/Chief Executive Officer and Director at Nu-Med Plus, Inc..

Action: resigned
Role: President/Chief Executive Officer and Director

Exact text from the filing

Mr. Colvin submitted his resignation from the positions to which he had been appointed.

View on SEC.gov

Nu-Med Plus, Inc. filing history →

Source: SEC EDGAR

accession 0001548123-24-000118

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.